机构地区:[1]保定市第一中心医院口腔一科,保定天使牙博士口腔医院,河北保定071000
出 处:《生物医学工程与临床》2022年第1期91-98,共8页Biomedical Engineering and Clinical Medicine
摘 要:目的探讨过氧化物酶体增殖物激活受体-γ2基因(PPAR-γ2)单核苷酸多态性(SNP)与糖化血红蛋白(HbA1c)水平的交互作用和糖尿病性牙周炎(DP)易感性的关系。方法选择2017年8月至2020年4月于保定市第一中心医院就诊的DP患者259例,其中男性138例,女性121例;年龄28~55岁,平均年龄42.98岁;体质量指数(BMI)22.42~32.13 kg/m^(2),平均BMI 27.25 kg/m^(2);吸烟64例,高血压史78例。2型糖尿病(T2DM)患者257例,其中男性124例,女性133例;年龄31~59岁,平均年龄43.31岁;BMI 22.74~29.88 kg/m^(2),平均BMI 25.87 kg/m^(2);吸烟56例,高血压史85例。选择同期接受健康体检者180例作为对照组,其中男性94例,女性86例;年龄28~60岁,平均年龄43.30岁;BMI 21.13~27.03 kg/m^(2),平均BMI 22.57 kg/m^(2);吸烟30例,高血压史69例。采用全自动生化仪检测T2DM患者HbA1c水平;采用双脱氧末端终止法检测PPAR-γ2 Pro12Ala SNP;采用多因素Logistic回归模型分析DP发生的危险因素,估算PPAR-γ2Pro12Ala SNP和HbA1c水平与DP发病风险的调整比值比(OR)和95%可信区间(95%CI);分析Pro12Ala SNP与HbA1c水平的交互作用。结果对照组、T2DM组及DP组患者HbA1c水平分别为5.12%±0.97%、7.95%±1.21%和9.12%±1.35%,组间比较差异具有统计学意义(P <0.05)。基因分型后可得纯合子Pro/Pro(P/P)型片段为224 bp、43 bp,杂合突变Pro/Ala(P/A)型片段为276 bp、224 bp、43 bp,纯合突变Ala/Ala(A/A)型片段为267 bp。Pro12Ala(PA)、Pro12Ala(AA)基因型T2DM患者患DP的风险均增加(OR=2.529,95%CI为1.637~3.498;OR=2.594,95%CI为1.645~3.856)。6.0%≤HbA1c <8.0%和HbA1c≥8.0%的T2DM患者患DP的风险明显增加(OR=2.046,95%CI为1.358~2.952;OR=3.105,95%CI为2.049~4.861),且HbA1c≥8.0%的T2DM患者患DP的风险又明显高于6.0%≤HbA1c <8.0%的T2DM患者(χ^(2)=6.087,P <0.01);HbA1c水平与Pro12Ala(PA)、Pro12Ala(AA)均存在正向交互作用(γ> 1)。结论携带Pro12Ala(PA)、Pro12Ala(AA)基因型的个体属DP高危人群,这些基因型与HbA1c水�Objective To investigate the relationship between peroxisome proliferator activated receptor-γ2 gene(PPAR-γ2) single nucleotide polymorphism and glycosylated hemoglobin( HbA1 c) level and susceptibility to diabetic periodontitis( DP).Method From August 2017 to April 2020, a total of 259 DP patients were enrolled, which included 138 males and 121 females, aged 28-55 years old with mean age of 42.98 years old;body mass index(BMI) was 22.42-32.13 kg/m^(2) with mean BMI of27.25 kg/m^(2);64 cases with smoking history and 78 with hypertension. The 257 patients with type 2 diabetes mellitus(T2 DM)were set as T2 DM group, which included 124 males and 133 females, aged 31-59 years old with mean age of 43.31 years old;BMI was 22.74-29.88 kg/m^(2) with mean BMI of 25.87 kg/m^(2);56 cases with smoking history and 85 with hypertension.Meanwhile, 180 healthy physical examination subjects were set as control group, which included 94 males and 86 females;aged 28-60 years old with mean age of 43.30 years old;BMI was 21.13-27.03 kg/m^(2) with mean BMI of 22.57 kg/m^(2);30 subjects with smoking history and 69 with hypertension. The multivariate Logistic regression model was used to analyze risk factors of DP, and estimate adjusted odds ratio(OR) and 95 % confidence interval(95 % CI) of PPAR-γ2 Pro12 Ala SNP and HbA1 c levels to DP risk. The interaction between Pro12 Ala SNP and HbA1 c level was analyzed. Results The levels of HbA1 c in control group, T2 DM group and DP group were 5.12 % ± 0.97 %, 7.95 % ± 1.21 % and 9.12 % ± 1.35 %, respectively, and the differences between the groups were statistically significant(P < 0.05). After genotyping, homozygous Pro/Pro(P/P)fragment was 224 bp and 43 bp, heterozygous mutant Pro/Ala(P/A) fragment was 276 bp, 224 bp and 43 bp, and homozygous mutant Ala/Ala(A/A) fragment was 267 bp. Patients with Pro12 Ala(PA) and Pro12 Ala(AA) genotype T2 DM had an increased risk to DP(OR = 2.529, 95 % CI 1.637-3.498;OR = 2.594, 95 % CI 1.645-3.856). The risk of DP in T2 DM patients with 6.0 % ≤ HbA1
关 键 词:过氧化物酶体增殖物激活受体-γ2(PPAR-γ2) 糖化血红蛋白(HbA1c) 糖尿病性牙周炎 单核苷酸多态性 交互作用
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...